Question 1: How safe are ACE inhibitors for heart failure in children?
Arch Dis Child
.
2018 Jan;103(1):106-109.
doi: 10.1136/archdischild-2017-312774.
Epub 2017 Oct 26.
Authors
Marijke van der Meulen
1
,
Michiel Dalinghaus
1
,
Michael Burch
2
,
Andras Szatmari
3
,
Cristina Castro Diez
4
,
Feras Khalil
4
,
Vanessa Swoboda
5
,
Johannes Breur
6
,
Milica Bajcetic
7
,
Ida Jovanovic
8
,
Florian B Lagler
9
,
Ingrid Klingmann
10
,
Stephanie Laeer
11
,
Saskia N de Wildt
12
Affiliations
1
Department of Pediatric Cardiology, Erasmus MC - Sophia, Rotterdam, The Netherlands.
2
Cardiothoracic Unit, Great Ormond Street Hospital, London, UK.
3
Department of Pediatric Cardiology, Göttsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary.
4
Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine Universität Düsseldorf, Dusseldorf, Germany.
5
Medical University of Vienna, Vienna, Austria.
6
Department of Pediatric Cardiology, Wilhelmina Children's Hospital University Medical Center, Utrecht, Utrecht, The Netherlands.
7
Univerzitetska Dečja Klinika, Belgrade, Serbia.
8
Clinical Pharmacology Unit, University Children's Hospital, Belgrade, Serbia.
9
Paracelsus Medizinische Privatuniversitat, Salzburg, Austria.
10
Pharmaplex bvba, Wezembeek_Oppem, Belgium.
11
Department of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-Universität, Düsseldorf, Germany.
12
Department of Pharmacology and Toxicology, Radboud University, Nijmegen, The Netherlands.
PMID:
29074732
DOI:
10.1136/archdischild-2017-312774
No abstract available
Keywords:
ace-inhibitor; adverse events; adverse reactions; heart failure; paediatric.